Prognostic impact of serum alpha-fetoprotein in patients with hepatocellular carcinoma: an international collaborative study

Broadhurst, P.; Toyoda, H.; Kumada, T.; Schweitzer, N.; Vogel, A.; Benckert, J.; Berg, T.; Best, J.; Dechêne, A.; Weinmann, A.; Galle, P.; Yeo, W.; Chan, S. L.; Berhane, S.; Palmer, D.; Cross, T.; Stern, N.; Reeves, H.; Johnson, P.

Published in

Elsevier, Journal of Hepatology, 1(66), p. S620-S621

DOI: 10.1016/s0168-8278(17)31684-7

Tools

Export citation

Search in Google Scholar

Prognostic impact of serum alpha-fetoprotein in patients with hepatocellular carcinoma: an international collaborative study

Journal article published in 2017 by P. Broadhurst, H. Toyoda, T. Kumada, N. Schweitzer, A. Vogel, J. Benckert, T. Berg, J. Best, A. Dechêne, A. Weinmann, P. Galle, W. Yeo, S. L. Chan

, S. Berhane, D. Palmer and other authors.

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Preprint: archiving allowed

Upload

Postprint: archiving forbidden

Published version: archiving forbidden

Policy details

Data provided by

Published in

Links

Tools

Prognostic impact of serum alpha-fetoprotein in patients with hepatocellular carcinoma: an international collaborative study